HOXB9 and endometrial carcinoma: In the Endometrial Carcinoma dataset (CPTAC, Cell 2020), HOXB9 was altered in 2.47% of 81 cases, whereas in the Uterine Corpus Endometrial Carcinoma dataset (TCGA, Firehose Legacy), HOXB9 was altered in 2.2% of 545 cases.